Bradford vs. Lowry Protein Assays: Which Is More Accurate?
9 May 2025
When it comes to protein quantification, two of the most common methods utilized in laboratories are the Bradford and Lowry protein assays. Both techniques have their distinct advantages and limitations, leading many scientists and researchers to wonder: which is more accurate? In this blog, we'll delve into the details of each method, comparing their accuracy and helping you decide which might be more suitable for your specific needs.
The Bradford protein assay, developed by Marion M. Bradford in 1976, is a rapid and straightforward method that relies on the binding of Coomassie Brilliant Blue dye to proteins. The assay measures the shift in absorbance maximum of the dye when it binds to protein molecules. One of the primary advantages of the Bradford assay is its speed and simplicity, making it a popular choice for many laboratories. It requires no heating or incubation, and the results can be obtained in just a few minutes. Furthermore, the Bradford assay is highly sensitive and specifically suits samples with low protein concentrations.
However, the Bradford assay is not without its drawbacks. Its accuracy can be compromised by the presence of detergents, buffer components, and other substances in the sample that can interfere with the dye binding process. These interferences can lead to an underestimation or overestimation of protein concentration. Additionally, the Bradford assay primarily detects arginine residues, which means that proteins with low arginine content may yield less accurate results.
On the other hand, the Lowry protein assay, developed by Oliver H. Lowry and colleagues in 1951, is based on the reaction of protein molecules with copper ions under alkaline conditions followed by the reduction of the Folin-Ciocalteu reagent. This method is more sensitive than the Bradford assay and tends to be more accurate for complex mixtures and proteins with low arginine content. The Lowry assay is less susceptible to interference from common laboratory reagents, making it a more reliable choice for samples that contain a variety of contaminants.
Despite its advantages, the Lowry assay is more time-consuming and complex than the Bradford assay. It involves multiple steps, including incubation periods that can take up to an hour, making it less convenient for high-throughput settings. Additionally, certain substances, such as reducing agents and EDTA, can interfere with the Lowry assay, potentially affecting its accuracy.
When deciding between the Bradford and Lowry protein assays, the choice ultimately depends on the specific needs and conditions of your experiment. If you require a quick and easy method with reasonable accuracy, especially for samples with low protein concentrations, the Bradford assay may be the preferable option. However, if your samples are complex and contain potential interfering substances, or if you need a more precise quantification, the Lowry assay might be more suitable.
In conclusion, both the Bradford and Lowry protein assays have their own strengths and weaknesses in terms of accuracy. Understanding these factors and considering the nature of your samples will help you choose the most appropriate method for your protein quantification needs. Each assay has its place in the laboratory, and knowing when to use one over the other can enhance the reliability of your results.
Discover Eureka LS: AI Agents Built for Biopharma Efficiency
Stop wasting time on biopharma busywork. Meet Eureka LS - your AI agent squad for drug discovery.
▶ See how 50+ research teams saved 300+ hours/month
From reducing screening time to simplifying Markush drafting, our AI Agents are ready to deliver immediate value. Explore Eureka LS today and unlock powerful capabilities that help you innovate with confidence.
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.